Crossmark

Lactobacillus helveticus R0052 alleviates liver injury by modulating gut microbiome and metabolome in d-galactosamine-treated rats

Crossref DOI link: https://doi.org/10.1007/S00253-019-10211-8

Published: 2019-12

Update policy: https://doi.org/10.1007/SPRINGER_CROSSMARK_POLICY

Authors

Wang, Qiangqiang http://orcid.org/0000-0003-1212-4492
Lv, Longxian

Jiang, Huiyong

Wang, Kaicen

Yan, Ren

Li, Yating http://orcid.org/0000-0002-0761-4967
Ye, Jianzhong http://orcid.org/0000-0001-8174-2580
Wu, Jingjing http://orcid.org/0000-0001-9289-0538
Wang, Qing http://orcid.org/0000-0003-4914-5473
Bian, Xiaoyuan http://orcid.org/0000-0002-7275-3103
Yang, Liya http://orcid.org/0000-0002-7832-983X
Jiang, Xianwan http://orcid.org/0000-0003-0982-7306
Xie, Jiaojiao

Lu, Yanmeng

Shen, Jian

Li, Lanjuan http://orcid.org/0000-0001-6945-0593
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (81570512, 81790631)

National Basic Research Program of China (973 Program) (2018YFC2000500)

Natural Science Foundation of Zhejiang Province (LQ19H030007)
License Information

Text and Data Mining valid from 2019-11-12
More Information

Article History

Received: 31 July 2019

Revised: 14 October 2019

Accepted: 20 October 2019

First Online: 12 November 2019

Compliance with ethical standards

:

: The authors declare that they have no conflict of interest.

: This study was approved by the Animal Care and Use Committee of the First Affiliated Hospital, School of Medicine, Zhejiang University (permit no. 2019-1068).